Institut Pasteur du Cambodge, Réseau international des Instituts Pasteur, Phnom Penh, Cambodia.
PLoS Negl Trop Dis. 2012;6(12):e1993. doi: 10.1371/journal.pntd.0001993. Epub 2012 Dec 27.
Dengue diagnosis is complex and until recently only specialized laboratories were able to definitively confirm dengue infection. Rapid tests are now available commercially making biological diagnosis possible in the field. The aim of this study was to evaluate a combined dengue rapid test for the detection of NS1 and IgM/IgG antibodies. The evaluation was made prospectively in the field conditions and included the study of the impact of its use as a point-of-care test for case management as well as retrospectively against a panel of well-characterized samples in a reference laboratory.
METHODOLOGY/PRINCIPAL FINDINGS: During the prospective study, 157 patients hospitalized for a suspicion of dengue were enrolled. In the hospital laboratories, the overall sensitivity, specificity, PPV and NPV of the NS1/IgM/IgG combination tests were 85.7%, 83.9%, 95.6% and 59.1% respectively, whereas they were 94,4%, 90.0%, 97.5% and 77.1% respectively in the national reference laboratory at Institut Pasteur in Cambodia. These results demonstrate that optimal performances require adequate training and quality assurance. The retrospective study showed that the sensitivity of the combined kit did not vary significantly between the serotypes and was not affected by the immune status or by the interval of time between onset of fever and sample collection. The analysis of the medical records indicates that the physicians did not take into consideration the results obtained with the rapid test including for care management and use of antibiotic therapy.
In the context of our prospective field study, we demonstrated that if the SD Bioline Dengue Duo kit is correctly used, a positive result highly suggests a dengue case but a negative result doesn't rule out a dengue infection. Nevertheless, Cambodian pediatricians in their daily practice relied on their clinical diagnosis and thus the false negative results obtained did not directly impact on the clinical management.
登革热的诊断较为复杂,直到最近,只有专门的实验室才能明确确认登革热感染。现在市面上有快速检测试剂,使得在现场进行生物诊断成为可能。本研究旨在评估一种用于检测 NS1 和 IgM/IgG 抗体的联合登革热快速检测试剂。该评估是在现场条件下进行的前瞻性研究,包括研究其作为现场护理点检测试剂用于病例管理的影响,以及回顾性研究在参考实验室中对一组特征明确的样本的影响。
方法/主要发现:在前瞻性研究中,纳入了 157 名因疑似登革热而住院的患者。在医院实验室中,NS1/IgM/IgG 联合检测的总体敏感性、特异性、PPV 和 NPV 分别为 85.7%、83.9%、95.6%和 59.1%,而在柬埔寨巴斯德研究所的国家参考实验室中,分别为 94.0%、90.0%、97.5%和 77.1%。这些结果表明,最佳性能需要充分的培训和质量保证。回顾性研究表明,联合试剂盒的敏感性在血清型之间没有显著差异,也不受免疫状态或发热与样本采集之间时间间隔的影响。对病历的分析表明,医生并未考虑快速检测结果,包括病例管理和抗生素治疗的使用。
在我们的前瞻性现场研究中,我们证明了如果正确使用 SD Bioline Dengue Duo 试剂盒,阳性结果高度提示登革热病例,但阴性结果不能排除登革热感染。然而,柬埔寨儿科医生在日常实践中依赖于他们的临床诊断,因此获得的假阴性结果并没有直接影响临床管理。